Factor VIII–von Willebrand factor–intrinsic tenase complex (FVIII-VWF-FIXa)

The Factor VIII–von Willebrand factor–intrinsic tenase complex is a multi-component protein assembly essential for blood coagulation. In the resting state, Factor VIII (FVIII) circulates as a complex with von Willebrand factor (vWF), which protects FVIII from proteolytic degradation and clearance (StatPearls, 2023). Upon vascular injury, thrombin activates FVIII to FVIIIa, leading to its dissociation from vWF and subsequent assembly with activated Factor IX (FIXa) and calcium on phospholipid surfaces to form the intrinsic tenase complex (PubMed, 2019). This enzymatic complex is responsible for the proteolytic activation of Factor X to Factor Xa, a rate-limiting step that amplifies the coagulation cascade (NIH, 2022). Deficiencies in FVIII or vWF lead to Hemophilia A and von Willebrand disease, respectively, characterized by impaired secondary hemostasis and bleeding (PubMed, 2021). Therapeutic interventions include replacement factors, vWF concentrates, and mimetic agents like emicizumab, which restores tenase-like activity in the absence of functional FVIII (NEJM, 2017).

Other names

FVIII-VWF complexIntrinsic tenaseFactor VIIIa-Factor IXa complexTenase complexFVIII-VWF-FIXa-FX assembly

Replacement of deficient coagulation factors or mimetic activity to facilitate the assembly of the tenase complex and subsequent Factor X activation.